07:00 , Apr 10, 2006 |  BC Week In Review  |  Company News

AdipoGenix, Unigen Pharmaceuticals Inc. deal

The companies partnered to discover and develop plant-based therapeutics that target adipose cells. AdipoGenix will use its technologies to discover natural compounds that reduce fat content of human fat cells from Unigen's collection of medicinal...
08:00 , Mar 20, 2006 |  BC Week In Review  |  Company News

AdipoGenix, J&J deal

AdipoGenix received an undisclosed milestone payment from JNJ under their 2002 deal to use AdipoGenix's human fat cell technologies to screen JNJ's obesity compounds (see BioCentury, Dec. 23, 2002). The payment was triggered by AdipoGenix...
07:00 , Aug 8, 2005 |  BC Week In Review  |  Company News

AdipoGenix scientific advisory board update

AdipoGenix Inc., Boston, Mass.   Business: Endocrine   Appointed: Richard Bergman, professor of physiology and biophysics at the University of Southern California School of Medicine; George Bray, executive director of the Pennington Biomedical Research Center; Manuel Navia,...
07:00 , Jun 27, 2005 |  BC Week In Review  |  Company News

AdipoGenix management update

AdipoGenix Inc., Boston, Mass.   Business: Endocrine, Cardiovascular   Hired: Nils Bergenhem as CSO, formerly VP of research at the Institute for Diabetes Discovery   ...
08:00 , Jan 10, 2005 |  BC Week In Review  |  Company News

AdipoGenix management update

AdipoGenix Inc., Boston, Mass.   Business: Metabolic   Hired: Ed Cannon as president and CEO, formerly president and CEO of Elixir Pharmaceuticals Inc.; he replaces Tom Vogel, who will remain a director   ...
08:00 , Jan 7, 2005 |  BC Extra  |  Company News

AdipoGenix names Cannon CEO

AdipoGenix (Boston, Mass.) hired Ed Cannon as president and CEO. Cannon formerly was president and CEO of Elixir ( Cambridge, Mass.). He replaces Tom Vogel, who will remain a director. AdipoGenix is testing its AGX-0104,...
08:00 , Nov 24, 2003 |  BC Week In Review  |  Company News

AdipoGenix, J&J deal

Under a 2002 deal, AdipoGenix received from JNJ an undisclosed milestone triggered by the screening and identification of candidates to treat obesity. AdipoGenix Inc., Boston, Mass.   Johnson & Johnson (JNJ), New Brunswick, N.J.   Business: Metabolic...
08:00 , Nov 24, 2003 |  BC Week In Review  |  Company News

AdipoGenix board of directors update

AdipoGenix Inc., Boston, Mass.   Business: Metabolic   Appointed: Gerry Brunk, partner at MDS Capital   ...
08:00 , Dec 23, 2002 |  BC Week In Review  |  Company News

AdipoGenix, J&J deal

The companies will develop therapeutics for obesity. AdipoGenix will use its human fat cell technologies to screen JNJ compounds and will run mechanistic studies on resulting leads. AdipoGenix will receive upfront fees, milestones and licensing...
08:00 , Dec 17, 2002 |  BC Extra  |  Company News

AdipoGenix, JNJ obesity deal

AdipoGenix (Boston, Mass.) and Johnson & Johnson (JNJ) partnered to develop therapeutics for obesity. AdipoGenix will use its human fat cell technologies to screen JNJ compounds and will run mechanistic studies on resulting leads. AdipoGenix...